These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 31876714)
1. Anaplastic lymphoma kinase-negative pulmonary inflammatory myofibroblastic tumor with multiple metastases and its treatment by Apatinib: A case report. Liu Q; Wei J; Liu X; Wang J Medicine (Baltimore); 2019 Dec; 98(52):e18414. PubMed ID: 31876714 [TBL] [Abstract][Full Text] [Related]
2. ALK-negative lung inflammatory myofibroblastic tumor in a young adult: A case report and literature review of molecular alterations. Debonis SA; Bongiovanni A; Pieri F; Fausti V; De Vita A; Riva N; Gurrieri L; Vanni S; Diano D; Mercatali L; Ibrahim T Medicine (Baltimore); 2021 May; 100(20):e25972. PubMed ID: 34011083 [TBL] [Abstract][Full Text] [Related]
3. Anaplastic lymphoma kinase-positive pulmonary inflammatory myofibroblastic tumor with sarcomatous morphology and distant metastases: An unusual histomorphology and behavior. Sethi B; Pai T; Allam A; Epari S Indian J Pathol Microbiol; 2015; 58(4):509-12. PubMed ID: 26549078 [TBL] [Abstract][Full Text] [Related]
4. [Case of an Inflammatory Myofibroblastic Tumor of the Duodenum]. Park SG; Kim GH; Park HJ; Kahng DH; Lee BE; Park DY Korean J Gastroenterol; 2018 Jul; 72(1):28-32. PubMed ID: 30049175 [TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant crizotinib in advanced inflammatory myofibroblastic tumour with ALK gene rearrangement. Rafee S; Elamin YY; Joyce E; Toner M; Flavin R; McDermott R; Sheehy N; Hennessy B; O'Byrne K; Gleeson N; Osman N Tumori; 2015 Apr; 101(2):e35-9. PubMed ID: 25744866 [TBL] [Abstract][Full Text] [Related]
6. Bilateral multiple inflammatory myofibroblastic tumors of the lung successfully treated with corticosteroids. Lee MH; Lee HB; Lee YC; Rhee YK; Lee EJ; Chung MJ; Jin GY; Kweon EY; Park SJ Lung; 2011 Oct; 189(5):433-5. PubMed ID: 21809057 [TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE. Schöffski P; Kubickova M; Wozniak A; Blay JY; Strauss SJ; Stacchiotti S; Switaj T; Bücklein V; Leahy MG; Italiano A; Isambert N; Debiec-Rychter M; Sciot R; Lee CJ; Speetjens FM; Nzokirantevye A; Neven A; Kasper B Eur J Cancer; 2021 Oct; 156():12-23. PubMed ID: 34392187 [TBL] [Abstract][Full Text] [Related]
8. ALK-negative urachal inflammatory myofibroblastic tumor in an elderly female: A case report. Wang K; Zhou H; Lu Y; Lu Q; Zhang C; Zhou X; Xia S; Wang G Medicine (Baltimore); 2018 Dec; 97(51):e13619. PubMed ID: 30572472 [TBL] [Abstract][Full Text] [Related]
9. ALK inhibition in two emblematic cases of pediatric inflammatory myofibroblastic tumor: Efficacy and side effects. Brivio E; Zwaan CM Pediatr Blood Cancer; 2019 May; 66(5):e27645. PubMed ID: 30697903 [TBL] [Abstract][Full Text] [Related]
10. "How long does crizotinib work? a rare case of recurrent inflammatory myofibroblastic tumor". Albayrak HC; Gürler F; Sütçüoğlu O; Akyürek N; Özet A Anticancer Drugs; 2022 Jan; 33(1):109-111. PubMed ID: 34261914 [TBL] [Abstract][Full Text] [Related]
11. ALK-positive gastric inflammatory myofibroblastic tumor in an adult with familial adenomatous polyposis and diffuse fundic polyposis. Fan J; Huang B; Yang X; Yang M; He J; Nie X Diagn Pathol; 2017 Sep; 12(1):68. PubMed ID: 28923119 [TBL] [Abstract][Full Text] [Related]
12. Complete and Repeated Response of a Metastatic ALK-rearranged Inflammatory Myofibroblastic Tumor to Crizotinib in a Teenage Girl. Gaudichon J; Jeanne-Pasquier C; Deparis M; Veyssière A; Heyndrickx M; Minckes O; Orbach D J Pediatr Hematol Oncol; 2016 May; 38(4):308-11. PubMed ID: 26808369 [TBL] [Abstract][Full Text] [Related]
13. Durable response to the ALK inhibitor alectinib in inflammatory myofibroblastic tumor of the head and neck with a novel SQSTM1-ALK fusion: a case report. Honda K; Kadowaki S; Kato K; Hanai N; Hasegawa Y; Yatabe Y; Muro K Invest New Drugs; 2019 Aug; 37(4):791-795. PubMed ID: 30790150 [TBL] [Abstract][Full Text] [Related]
14. Gastric and cardiac inflammatory myofibroblastic tumor: an extremely rare case. Huang Y; Zhang M; Li Q; Huang Q J Cardiothorac Surg; 2024 Jan; 19(1):31. PubMed ID: 38287440 [TBL] [Abstract][Full Text] [Related]
15. Significant efficacy and well safety of apatinib combined with radiotherapy in NSCLC: Case report. Zhao C; Zhang Q; Qiao W Medicine (Baltimore); 2017 Dec; 96(50):e9276. PubMed ID: 29390380 [TBL] [Abstract][Full Text] [Related]
16. [Exceptional bilocular inflammatory myofibroblastic pseudotumour (IMT) characterized by recurrent thoracic tumour growth and a rare (adult) second manifestation within the mesenteric tissue of the small intestine]. Petersen M; Kuester D; Roessner A; Schütte K; Lippert H; Meyer F Z Gastroenterol; 2010 May; 48(5):555-9. PubMed ID: 20140844 [TBL] [Abstract][Full Text] [Related]
17. Uterine metastases originating from a pulmonary inflammatory myofibroblastic tumor. Zhang J; Li Y; Lou L J Cancer Res Ther; 2018; 14(Supplement):S257-S259. PubMed ID: 29578184 [TBL] [Abstract][Full Text] [Related]
18. Drastic initial response and subsequent response to two ALK inhibitors in a patient with a highly aggressive ALK-rearranged inflammatory myofibroblastic tumor arising in the pleural cavity. Ono A; Murakami H; Serizawa M; Wakuda K; Kenmotsu H; Naito T; Taira T; Koh Y; Ohde Y; Nakajima T; Endo M; Takahashi T Lung Cancer; 2016 Sep; 99():151-4. PubMed ID: 27565932 [TBL] [Abstract][Full Text] [Related]
19. Pulmonary epithelioid inflammatory myofibroblastic sarcoma with multiple bone metastases: case report and review of literature. Fu X; Jiang J; Tian XY; Li Z Diagn Pathol; 2015 Jul; 10():106. PubMed ID: 26178751 [TBL] [Abstract][Full Text] [Related]